Lacosamide ARX (Lacosamide)
lacosamide 200 mg tablet, 56 · ORAL · PBS code 13949E
STREAMLINEDWhat it costs
AU$91.3 PBS-determined price per 112 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2024-03-01.
- • Repeats: 5.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Idiopathic generalised epilepsy with primary generalised tonic-clonic seizures
The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
Must be treated by a neurologist; or
Must be treated by a paediatrician; or
Must be treated by an eligible practitioner type who has consulted at least one of the above mentioned specialist types, with agreement reached that the patient should be treated with this pharmaceutical benefit on this occasion; AND
The condition must have failed to be controlled satisfactorily by at least two antiseizure medications prior to when the drug is/was first commenced; AND
The treatment must have been in combination with at least one PBS-subsidised antiseizure medication at the time the drug was first commenced.
Sponsor: Arrotex Pharmaceuticals Pty Ltd ABN 30 605 552 234
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.